Outcomes of Adults and Children with Primary Mediastinal B-Cell Lymphoma Treated with Dose-Adjusted EPOCH-R

Treatment with dose-adjusted EPOCH (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone) chemotherapy and rituximab (DA-EPOCH-R) has become the standard of care for primary mediastinal B-cell lymphoma (PMBCL) at many institutions despite limited data in the multi-centre setting. We rep...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Haematol
Päätekijät: Giulino-Roth, Lisa, O’Donohue, Tara, Chen, Zhengming, Bartlett, Nancy L., LaCasce, Ann, Martin-Doyle, William, Barth, Matthew J., Davies, Kimberly, Blum, Kristie A., Christian, Beth, Casulo, Carla, Smith, Sonali M., Godfrey, James, Termuhlen, Amanda, Oberley, Matthew J., Alexander, Sarah, Weitzman, Sheila, Appel, Burton, Mizukawa, Benjamin, Svoboda, Jakub, Afify, Zeinab, Pauly, Melinda, Dave, Hema, Gardner, Rebecca, Stephens, Deborah M., Zeitler, William A., Forlenza, Christopher, Levine, Jennifer, Williams, Michael E., Sima, Jody L., Bollard, Catherine M., Leonard, John P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2017
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6650639/
https://ncbi.nlm.nih.gov/pubmed/29082519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.14951
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia